NCT07224568
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07224568
Title Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors (INTERCEPT)
Acronym INTERCEPT
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Children's Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.